← Leaderboards
Baldomero M Olivera
University Of Utah
$11,578,852
Attributed
$13,814,930
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,019,665 · 12
By mechanism
P01$42,368,173 · 10
R01$3,651,492 · 2
Top collaborators
- Shrinivasan Raghuraman6 shared
- Helena Safavi-Hemami6 shared
- Mark Douglas Yandell4 shared
Most similar at University Of Utah
Same institution · by research overlap
- Helena Safavi-Hemami$1,861,171
- Mark Douglas Yandell$10,527,606
- Lourdes J Cruz$1,296,270
- Shrinivasan Raghuraman$820,664
- J M McIntosh$450,687
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesConotoxinConus GenusReceptorLigandsVenomsProgramsPharmacologyIon ChannelPotassium ChannelSnailsMolecularLaboratoriesComplexPainStructurePhysiologicalBaseVoltagePharmaceutical PreparationsElectrophysiology (Science)FamilyCollaborationsMember
Grant awards (78)
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$575,070
R01 · FY2025 · GM · contact PI
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$575,070
R01 · FY2024 · GM · contact PI
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$574,453
R01 · FY2023 · GM · contact PI
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$153,370
R01 · FY2023 · GM · contact PI
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$10,811
R01 · FY2023 · GM · contact PI
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$573,218
R01 · FY2022 · GM · contact PI
Life history-guided drug discovery from venomous marine snails$297,375
R01 · FY2022 · GM
Life history-guided drug discovery from venomous marine snails$297,375
R01 · FY2021 · GM
Life history-guided drug discovery from venomous marine snails$297,375
R01 · FY2020 · GM
Life history-guided drug discovery from venomous marine snails$297,375
R01 · FY2019 · GM
Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology.$2,005,656
P01 · FY2018 · GM · contact PI
Project I: Constellation Pharmacology$408,641
P01 · FY2018 · GM · contact PI
Admin Core$215,977
P01 · FY2018 · GM · contact PI
Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology.$2,005,656
P01 · FY2017 · GM · contact PI
Project I: Constellation Pharmacology$408,641
P01 · FY2017 · GM · contact PI
Admin Core$215,977
P01 · FY2017 · GM · contact PI
Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology.$2,007,869
P01 · FY2016 · GM · contact PI
Project I: Constellation Pharmacology$410,939
P01 · FY2016 · GM · contact PI
Admin Core$208,201
P01 · FY2016 · GM · contact PI
Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology.$107,914
P01 · FY2016 · GM · contact PI
Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology.$1,991,624
P01 · FY2015 · GM · contact PI
Project I: Constellation Pharmacology$380,967
P01 · FY2015 · GM · contact PI
Admin Core$223,581
P01 · FY2015 · GM · contact PI
Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology.$22,410
P01 · FY2015 · GM · contact PI
Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology.$2,376,903
P01 · FY2014 · GM · contact PI
Project I: Constellation Pharmacology$380,275
P01 · FY2014 · GM · contact PI
Admin Core$215,976
P01 · FY2014 · GM · contact PI
Conus Peptides and Their Receptor Targets$596,000
P01 · FY2013 · GM · contact PI
Conus Peptides and Their Receptor Targets$22,496
P01 · FY2013 · GM · contact PI
Conus Peptides and Their Receptor Targets$1,738,049
P01 · FY2012 · GM · contact PI
Conopeptides - K+ Channels$257,227
P01 · FY2012 · GM · contact PI
Administrative Core$173,419
P01 · FY2012 · GM · contact PI
Conus Peptides and Their Receptor Targets$1,755,644
P01 · FY2011 · GM · contact PI
Conopeptides - K+ Channels$264,467
P01 · FY2011 · GM · contact PI
Administrative Core$178,678
P01 · FY2011 · GM · contact PI
Conus Peptides and Their Receptor Targets$1,778,571
P01 · FY2010 · GM · contact PI
Conopeptides - K+ Channels$264,288
P01 · FY2010 · GM · contact PI
Administrative Core$179,183
P01 · FY2010 · GM · contact PI
Conus Peptides and Their Receptor Targets$21,260
P01 · FY2010 · GM · contact PI
Conus Peptides and Their Receptor Targets$1,769,893
P01 · FY2009 · GM · contact PI
Conus Peptides and Their Receptor Targets$687,001
P01 · FY2009 · GM · contact PI
Conopeptides - K+ Channels$258,491
P01 · FY2009 · GM · contact PI
Administrative Core$175,875
P01 · FY2009 · GM · contact PI
Conus Peptides and Their Receptor Targets$2,092,340
P01 · FY2008 · GM · contact PI
Conopeptides - K+ Channels$253,421
P01 · FY2008 · GM · contact PI
Administrative Core$172,523
P01 · FY2008 · GM · contact PI
Conus Peptides and Their Receptor Targets$1,653,963
P01 · FY2007 · GM · contact PI
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$456,732
P01 · FY2007 · GM · contact PI
CONANTOKINS: NMDA RECEPTOR SUBTYPES AND EPILEPSY$300,908
P01 · FY2007 · GM · contact PI
CONUS PEPTIDES AND K CHANNELS$266,261
P01 · FY2007 · GM · contact PI
CONOTOXINS AND HOMERIC NICOTINIC ACETYLCHOLINE RECEPTORS$181,612
P01 · FY2007 · GM · contact PI
Conus Peptides and Their Receptor Targets$1,655,250
P01 · FY2006 · GM · contact PI
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$322,265
P01 · FY2006 · GM · contact PI
CONANTOKINS: NMDA RECEPTOR SUBTYPES AND EPILEPSY$211,475
P01 · FY2006 · GM · contact PI
CONUS PEPTIDES AND K CHANNELS$187,127
P01 · FY2006 · GM · contact PI
CONOTOXINS AND HOMERIC NICOTINIC ACETYLCHOLINE RECEPTORS$127,636
P01 · FY2006 · GM · contact PI
Conus Peptides and Their Receptor Targets$1,574,246
P01 · FY2005 · GM
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$313,930
P01 · FY2005 · GM
CONANTOKINS: NMDA RECEPTOR SUBTYPES AND EPILEPSY$205,316
P01 · FY2005 · GM
CONUS PEPTIDES AND K CHANNELS$181,677
P01 · FY2005 · GM
CONOTOXINS AND HOMERIC NICOTINIC ACETYLCHOLINE RECEPTORS$123,918
P01 · FY2005 · GM
Conus Peptides and Their Receptor Targets$48,519
P01 · FY2005 · GM
Conus Peptides and Their Receptor Targets$1,541,592
P01 · FY2004 · GM
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$304,789
P01 · FY2004 · GM
CONANTOKINS: NMDA RECEPTOR SUBTYPES AND EPILEPSY$199,336
P01 · FY2004 · GM
CONUS PEPTIDES AND K CHANNELS$176,385
P01 · FY2004 · GM
CONOTOXINS AND HOMERIC NICOTINIC ACETYLCHOLINE RECEPTORS$120,309
P01 · FY2004 · GM
Conus Peptides and Their Receptor Targets$1,720,887
P01 · FY2003 · GM
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$295,911
P01 · FY2003 · GM
CONANTOKINS: NMDA RECEPTOR SUBTYPES AND EPILEPSY$210,780
P01 · FY2003 · GM
CONUS PEPTIDES AND K CHANNELS$162,832
P01 · FY2003 · GM
CONOTOXINS AND HOMERIC NICOTINIC ACETYLCHOLINE RECEPTORS$116,805
P01 · FY2003 · GM
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$1,034,205
P01 · FY2002 · GM
PHYSIOLOGICAL SYNERGISM BETWEEN CONOTOXINS$145,314
P01 · FY2002 · GM
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$1,010,519
P01 · FY2001 · GM
PHYSIOLOGICAL SYNERGISM BETWEEN CONOTOXINS$145,314
P01 · FY2001 · GM
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS$986,268
P01 · FY2000 · GM
PHYSIOLOGICAL SYNERGISM BETWEEN CONOTOXINS$160,059
P01 · FY2000 · GM